Skip to main content
drug_type
RELEVANT_DRUG
intervention_type
Antibody–drug conjugate (ADC)
drug_description
An antibody–drug conjugate that binds a tumor-associated surface antigen, is internalized, and releases a camptothecin-class/topoisomerase I inhibitor payload ("-gitecan"), inducing DNA damage and tumor cell death.
nci_thesaurus_definition
NCI thesaurus definition not available.
drug_category
ANTIBODY DRUG CONJUGATE
drug_class
Conjugate
drug_delivery_route
Intravenous
drug_mechanism_of_action
Antibody–drug conjugate that binds a tumor-associated surface antigen, is internalized, and releases a camptothecin-class/topoisomerase I inhibitor payload inside tumor cells, inducing DNA damage and tumor cell death.
drug_name
BL-B01D1 (izalontamab brengitecan; BMS-986507)
nct_id_drug_ref
NCT06475300